AbbVie's Q1 Good News That Investors Could Be Missing

AbbVie's Q1 Good News That Investors Could Be Missing

Submitted by admin on April 30, 2022 - 2:31pm
Source: 
Motley Fool
News Tags: 
AbbVie
Humira
earnings
Allergan
Headline: 
AbbVie's Q1 Good News That Investors Could Be Missing
snippet: 
  • AbbVie lowered its 2022 adjusted earnings guidance -- but for a positive reason.
  • The company's acquisition of Allergan is clearly making a difference.
  • AbbVie's post-Humira strategy appears to already be working.

Do Not Allow Advertisers to Use My Personal information